Dilantin and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is reported as a side effect among people who take Dilantin (phenytoin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neurontin, and have Convulsion.
The phase IV clinical study analyzes which people have Weakness when taking Dilantin. It is created by eHealthMe based on reports of 19,857 people who have side effects when taking Dilantin from the FDA, and is updated regularly.
What is Dilantin?
Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.
What is Weakness?
Weakness is found to be associated with 3,638 drugs and 6,592 conditions by eHealthMe. Check the latest studies of Weakness.
19,857 people reported to have side effects when taking Dilantin.
Among them, 1,050 people (5.29%) have Weakness.

Among these 1,050 people:
How long have people been on Dilantin when they have Weakness? *
What is the gender of people who have Weakness when taking Dilantin? *
What is the age of people who have Weakness when taking Dilantin? *
What are other drugs people take besides Dilantin? *
What are other side effects people have besides Weakness? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Dilantin and have Weakness?
- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Dilantin:
- Dilantin (20,858 reports)
Weakness treatments and more:
- Weakness (586,873 reports)
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of phenytoin sodium:
- Weakness and drugs with ingredients of phenytoin sodium (1,408 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dilantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weakness:
- Weakness (3,638 drugs)
Browse all the conditions that are associated with Weakness:
- Weakness (6,592 conditions)
Related publications that referenced our studies
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on phenytoin sodium (the active ingredients of Dilantin) and Dilantin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zyprexa vs. Aplenzin, side effect and effectiveness comparison - a second ago
- Could Ribavirin cause Tinnitus? - 2 seconds ago
- Could Ceftriaxone cause Cerebral Atrophy? - 4 seconds ago
- Vistaril vs. Lamictal, side effect and effectiveness comparison - 5 seconds ago
- Could Lamotrigine cause Thermal Burns Of Eye? - 6 seconds ago
- Could Simvastatin cause International Normalised Ratio Abnormal? - 10 seconds ago
- Could Dilaudid cause Cerebral Thrombosis? - 11 seconds ago
- Could Carvedilol cause Pulmonary Valve Disease? - 12 seconds ago
- Could Catapres cause Sleep Disorder? - 12 seconds ago
- Could Avelox cause Radiculitis Cervical? - 12 seconds ago